The DOI matches its Crossref record; 312 of the 321 references it cites were found in a registry or an index.
Allergen injection immunotherapy for seasonal allergic rhinitis
Open accessAbstract
BACKGROUND: Allergic rhinitis is the most common of the allergic diseases. Despite improved understanding of the pathophysiology of allergic rhinitis and advances in its pharmacological treatment, its prevalence has increased worldwide. For patients whose symptoms remain uncontrolled despite medical treatment, allergen injection immunotherapy is advised. An allergen-based treatment may reduce symptoms, the need for medication and modify the natural course of this disease. OBJECTIVES: To evaluate the efficacy and safety of subcutaneous specific allergen immunotherapy, compared with placebo, for reducing symptoms and medication requirements in seasonal allergic rhinitis patients. SEARCH STRATEGY: We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, Issue 1 2006), MEDLINE (1950 to 2006), EMBASE (1974 to 2006), Pre-MEDLINE, KOREAMED, INDMED, LILACS, PAKMEDINET, Scisearch, mRCT and the National Research Register. The date of the last search was February 2006. SELECTION CRITERIA: All studies identified by the searches were assessed to identify randomised controlled trials involving participants with symptoms of seasonal allergic rhinitis and proven allergen sensitivity, treated with subcutaneous allergen specific immunotherapy or corresponding placebo. DATA COLLECTION AND ANALYSIS: Two independent authors identified all studies reporting double-blind, placebo controlled randomised trials of specific immunotherapy in patients with seasonal allergic rhinitis due to tree, grass or weed pollens. Two authors independently performed quality assessment of studies. Data from identified studies were abstracted onto a standard extraction sheet and subsequently entered into RevMan 4.2.8. Analysis was performed using the Standardised Mean Difference (SMD) method and a random-effects model; P values < 0.05 were considered statistically significant. The primary outcome measures were symptom scores, medication use, quality of life and adverse events. MAIN RESULTS: We retrieved 1111 publications of which 51 satisfied our inclusion criteria. In total there were 2871 participants (1645 active, 1226 placebo), each receiving on average 18 injections. Duration of immunotherapy varied from three days to three years. Symptom score data from 15 trials were suitable for meta-analysis and showed an overall reduction in the immunotherapy group (SMD -0.73 (95% CI -0.97 to -0.50, P < 0.00001)). Medication score data from 13 trials showed an overall reduction in the immunotherapy group (SMD of -0.57 (95% CI -0.82 to -0.33, p<0.00001)). Clinical interpretation of the effect size is difficult. Adrenaline was given in 0.13% (19 of 14085 injections) of those on active treatment and in 0.01% (1 of 8278 injections) of the placebo group for treatment of adverse events. There were no fatalities. AUTHORS' CONCLUSIONS: This review has shown that specific allergen injection immunotherapy in suitably selected patients with seasonal allergic rhinitis results in a significant reduction in symptom scores and medication use. Injection immunotherapy has a known and relatively low risk of severe adverse events. We found no long-term consequences from adverse events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Total symptom score is the main variable in systematic reviews and meta-analyses, both in SCIT [172] and in SLIT in drops [173] or in tablets [174]; therefore, specific data on NO are not usually published [171].”
From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [172]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Beasley, R. W. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07302-9 · Cited by 3,794
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
Bousquet, J., Lockey, R. F., & Malling, H. ‐. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70271-4 · Cited by 1,582
Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy
Durham, S. R., Walker, S. M., Varga, E., Jacobson, M. R., O'Brien, F., Noble, W. J., Till, S. J., Hamid, Q. A., & Nouri‐Aria, K. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410702 · Cited by 1,371
Self-citationMöller, C., Dreborg, S., Ferdousi, H. A., Halken, S., Høst, A., Jacobsen, L., Koivikko, A., Koller, D. Y., Niggemann, B., Norberg, L. A., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121317 · Cited by 1,065
Flagged first, then by citations
9 of the 321 references couldn’t be matched to a known paper.
Research works printed but not linked: 29
- Brewczynski, 1999, Efficacy and safety of immunotherapy with modified grass pollen allergens. Results of a placebo-controlled study, Allergologie, 22, 411
- Hauser, 1995, Inhibitory effect on migration of inflammatory cells into the nasal mucosa by immunotherapy, Allergo Journal, 4, 164
- Berstein, 2001, Double blind placebo controlled (DBPC) study of grapeseed extract in the treatment of seasonal allergic rhinitis (SAR), Journal of Allergy and Clinical Immunology, 107, S311
- Calderon, 2003, Double blind placebo controlled study of specific immunotherapy (SIT) with Alutard SQ grass pollen for seasonal allergic rhinoconjunctivitis, Allergy and Clinical Immunology International, 1, Abstract No. O-
- Crimi, 2001, A randomised double-blind study of specific immunotherapy (SIT) in patients with seasonal allergic-rhinitis: effects on clinical and inflammatory markers, European Respiratory Journal, 18, 482s
- Egger, 1997, The influence of hypo-sensitisation therapy on the sense of smell in subjects with seasonal allergic rhinitis, Allergologie, 20, 525
- Frankland, 1963, Treatment of hay fever by depot injection (shypyrindene) in allergic conditions. Double blind clinical study, Acta Allergologica, 18, 175
- Kerr, 1964, The treatment of hay fever including a controlled trial of the use of alum precipitate pollen adsorbate, Acta Allergologica, 19, 76
- Kuhn, 1985, Hyposensitization in pollen sensitive children: A 3 year prospective study, Allergologie, 8, 103
- Lindsay-Miller, 1971, Pollen Tyrosine in the treatment of hay fever, Clinical Allergy, 1, 351
- Malling, 2000, Allergen specific immunotherapy for asthma, Ugeskr Laeger, 162 (4), 477
- Manger, 1984, Hyposensitization of hay fever patients with Tyrosin-adsorbed grass and rye pollen allergoid. Clinical and immunological parameters during different dosages with TA Tyrosin-Allergoid Gräserpollen, Allergologie, 7, 222
- Mewes, 1999, Short term immune therapy with ALK7 reduces grass-pollen induces rhinoconjunctivitis symptoms and the specific nasal reactivity is more efficient than a symptomatic standard therapy, Allergologie, 22, 581
- Nolte, 1999, Allergen extracts, dosing, efficacy and safety of immunotherapy, International Review of Allergology and Clinical Immunology, 5 (3), 184
- Osterballe, 1982, Immunotherapy in hay fever with timothy major allergens, Allergy, 37, 8
- Pastorello, 1988, A double blind placebo controlled trial of specific immunotherapy with aluminium hydroxide adsorbed allergoid in grass pollen induced rhinitis, Allergy, 43, 48
- Ricca, 1997, Preseasonal specific immunotherapy with modified Phleum pratense allergenic extracts: tolerability and effects, Allergologia et Immunopathologia (Madrid), 25, 167
- Rozniecka, 1995, The characteristics of pollinosis during the pollen season and the influence of specific immunotherapy. Part II: Cytologic changes and chemotactic activity in nasal lavage, Pneumonologia i Alergologia Polska, 63, 144
- Ruiz, 2001, Safety and efficacy of immunotherapy with a standardized depigmented and glutaraldehyde-polyerized extract of phleum pratense pollen, Journal of Allergy and Clinical Immunology, 107, S260
- Sandstrom, 2001, Xolair is effective in the treatment of seasonal birch pollen allergic rhinitis, Annals of Allergy, Asthma and Immunology, 86, 83
- Stuck, 2001, Birch pollen allergoid plus MPL in short-term immunotherapy, Otolaryngology - Head and Neck Surgery, 125, P199
- Sykora, 2004, Efficacy and safety of specific allergen immunotherapy with standardized depod allergen H-AI depot (pollens), Alergie, 6, 170
- Watanabe, 2003, Successful grass pollen immunotherapy inhibits eosinophil accumulation in the nasal mucosa: role of adhesion molecules and apoptosis [Abstract], Allergy and Clinical Immunology International, 15, Abstract No.O-1
- Williams, 2001, A study to determine the efficacy of a nasally administered rye grass peptide, Ptl-0901, in the treatment of severe seasonal hayfever, Journal of Allergy and Clinical Immunology, 107, S256
- Williams, 2002, Effectiveness of preseasonal allergoid immunotherapy in patients with grass pollen allergy [Abstract], Allergy, 57, 51
- Yariktas, 2002, Comparison of Leukotriene Receptor Antagonist and Antihistamine Therapy in Seasonal Allergic Rhinitis, Turkish Archives of Otolaryngology, 40, 252
- Frank, 2001, Effectiveness of a pre-seasonal allergoid immunotherapy in patients with seasonal allergic rhinitis due to grass pollen, Journal of Allergy and Clinical Immunology, 107, S260
- Committee of the Safety of Medicine, 1994, Desensitising vaccines: New advice, Current Problems in Pharmacovigilance, 20, 5
- Durham, 1999, Long-term clinical efficacy of grass-pollen immunotherapy, New England Journal of Medicine, 341(7), 468, 10.1056/NEJM199908123410702 · DOI
Cited by
Sorted by citations
Items 301–400 of 674
Nahm, D., & Kim, M. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2012.53.1.158 · Cited by 16
Understanding systematic reviews: the meta-analysis graph (also called ‘forest plot’)
Moja, L., Moschetti, I., Liberati, A., Gensini, G. F., & Gusinu, R. (2007) · Internal and Emergency Medicine · doi:10.1007/s11739-007-0036-8 · Cited by 16
Moradi, S., Khazaei, H., Tarlan, M., Jasemi, S. V., Joshi, T., Aneva, I. Y., Farzaei, M. H., & Echeverría, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1447097 · Cited by 16
Ryan, M. W., Marple, B. F., Leatherman, B. D., Mims, J. “., Fornadley, J. A., Veling, M. C., & Lin, S. Y. (2014) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21359 · Cited by 15
Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy
Frati, F., Incorvaia, C., David, M., Scurati, S., Seta, S., Padua, G., Cattaneo, E., Cavaliere, C., Rienzo, A. D., Dell'albani, I., et al. (2012) · Drug Design, Development and Therapy · doi:10.2147/dddt.s30908 · Cited by 20
Organ‐specific allergen challenges in airway allergy: Current utilities and future directions
Fauquert, J., Alba‐Linero, C., Gherasim, A., Testera‐Montes, A., Bentabol‐Ramos, G., Maria‐Garcia, R. S. D. S., Torres, M. J., Eguíluz‐Gracia, I., & Rondón, C. (2023) · Allergy · doi:10.1111/all.15731 · Cited by 16
Arguing the Misconceptions in Allergen-Specific Immunotherapy
Ridolo, E., Montagni, M., Bonzano, L., Senna, G., & Incorvaia, C. (2014) · Immunotherapy · doi:10.2217/imt.14.23 · Cited by 14
Subcutaneous Immunotherapy Improves the Symptomatology of Allergic Rhinitis
Lourenço, E. A., Caldeira, E. J., Carvalho, C., da Cunha, M. R., de Carvalho, M. V. H., & Passos, S. D. (2015) · International Archives of Otorhinolaryngology · doi:10.1055/s-0035-1564437 · Cited by 14
Jura-Szołtys, E., Gawlik, R., Branicka, O., Stryjewska‐Makuch, G., & Glück, J. (2022) · Advances in Dermatology and Allergology · doi:10.5114/ada.2022.117978 · Cited by 14
Iordache, A., Balica, N. C., Horhat, D. I., Morar, R., Tischer, A. A., Milcu, A. I., Salavat, M.-C. P., & Borugă, V. M. (2023) · PubMed Central · doi:10.12865/chsj.49.01.5 · Cited by 19
Pharmakoprophylaxe und Begleitmedikation bei spezifischer Immuntherapie
Wedi, B., & Ruëff, F. (2011) · Der Hautarzt · doi:10.1007/s00105-011-2157-2 · Cited by 14
Compliance With Subcutaneous Immunotherapy Appointments in an Urban Tertiary Care Setting
Keefe, K. R., Ngo-Howard, M., Platt, M. P., & Brook, C. D. (2018) · American Journal of Rhinology and Allergy · doi:10.1177/1945892418793518 · Cited by 14
Turkish Guidelines for Diagnosis and Treatment of Allergic Rhinitis (ART)
Ecevit, M. C., Özcan, M., Can, İ. H., Tatar, E. Ç., Özer, S., Esen, E., Atan, D., Göde, S., Elsürer, Ç., Eryılmaz, A., et al. (2021) · Turkish Archives of Otorhinolaryngology · doi:10.4274/tao.2021.suppl.1 · Cited by 14
Endonasal phototherapy with Rhinolight®for the treatment of allergic rhinitis
Brehmer, D. (2009) · Expert Review of Medical Devices · doi:10.1586/erd.09.56 · Cited by 14
Gerstlauer, M., Szépfalusi, Z., Golden, D. B. K., Geng, B., & Jacques de, B. L. I. C. (2019) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2019.04.011 · Cited by 14
Safety of cluster specific immunotherapy with a modified high-dose house dust mite extract.
García, A. N., Falcó, S. N., Díaz, T. C., Cumplido, J., Calderón, J. P. I., & Hernández-Peña, J. (2013) · PubMed · Cited by 14
Which Allergen Extract for Grass Pollen Immunotherapy? an in Vitro Study
Marcucci, F., SENSI, L. G., Cara, G. D., Incorvaia, C., Puccinelli, P., Scurati, S., & Frati, F. (2010) · Immunological Investigations · doi:10.3109/08820131003796876 · Cited by 13
Santos, N., Pereira, A. M., Silva, R., Costa, J. T., & Plácido, J. L. (2014) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2013.10.006 · Cited by 13
Benichou, A., Armanet, M., Bussière, A., Chevreau, N., Cardot, J., & Tétard, J. (2014) · Food Science & Nutrition · doi:10.1002/fsn3.147 · Cited by 13
Local and Systemic IgE in the Evaluation and Treatment of Allergy
Hoddeson, E. K., Pratt, E., Harvey, R. J., & Wise, S. K. (2010) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2010.02.009 · Cited by 14
Pogorelov, D., Bode, S. F. N., He, X., Ramiro‐Garcia, J., Hedin, F., Ammerlaan, W., Konstantinou, M., Capelle, C., Zeng, N., Poli, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54684-2 · Cited by 12
Immuntherapie der allergischen Rhinitis ohne Allergene?
Klimek, L., Willers, J., Schendzielorz, P., Kündig, T. M., & Senti, G. (2013) · HNO · doi:10.1007/s00106-013-2761-9 · Cited by 12
Calderón, M. A., & Cox, L. (2014) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2013.12.008 · Cited by 12
New developments in allergen immunotherapy
Vadlamudi, A., & Shaker, M. S. (2015) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000267 · Cited by 12
Allergic Fungal Rhinosinusitis
Kameswaran, M., Chopra, H., Kanojia, S., Janakiram, T. N., Vaid, N. B., Soni, A., Mohindroo, N., Charaya, K., Shah, N. J., Rai, D., et al. (2012) · Clinical Rhinology An International Journal · doi:10.5005/jp-journals-10013-1124 · Cited by 12
Hypoallergenic preparations in SCIT
Brehler, R., Kahlert, H., & Thum‐Oltmer, S. (2010) · Allergo Journal · doi:10.1007/bf03370748 · Cited by 12
Decision-making for pediatric allergy immunotherapy for aeroallergens: a narrative review
Tortajada‐Girbés, M., del Castillo, M. M., Larramona, H., Lucas, J. M., Lozano, M. A., Tabar, A. I., López, B. S., & Martínez‐Cañavate, A. (2019) · European Journal of Pediatrics · doi:10.1007/s00431-019-03444-2 · Cited by 12
The Role of Allergen-Specific Immunotherapy in ENT Diseases: A Systematic Review
Cantone, E., Gallo, S., Torretta, S., Detoraki, A., Cavaliere, C., Nola, C. D., Spirito, L., Cesare, T. D., Settimi, S., Furno, D., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060946 · Cited by 14
Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease
Creticos, P. S. (2022) · Allergy and Asthma Proceedings · doi:10.2500/aap.2022.43.220033 · Cited by 12
Santos, A. F., Borrego, L. M., Rotiroti, G., Scadding, G. K., & Roberts, G. C. (2015) · Clinical and Translational Allergy · doi:10.1186/s13601-014-0044-5 · Cited by 12
Mösges, R., Rohdenburg, C., Eichel, A., Zadoyan, G., Kasche, E.-M., Shah‐Hosseini, K., Lehmacher, W., Schmalz, P., & Compalati, E. (2017) · Immunotherapy · doi:10.2217/imt-2017-0058 · Cited by 12
Fujisawa, T., Shimoda, T., Masuyama, K., Okubo, K., Honda, K., Okano, M., Katsunuma, T., Urisu, A., Kondo, Y., Odajima, H., et al. (2017) · Allergology International · doi:10.1016/j.alit.2017.11.004 · Cited by 12
Positive and negative AIT trials: What makes the difference?
van Wijk, R. G. (2018) · Allergo Journal International · doi:10.1007/s40629-018-0058-y · Cited by 12
Subcutaneous Immunotherapy in Patients with Fagales Pollen-Induced Oral Allergy Syndrome
Kong, N., Kim, S., Lee, S. C., Park, K. H., Lee, J., & Park, J. (2019) · Yonsei Medical Journal · doi:10.3349/ymj.2019.60.4.389 · Cited by 12
HLA‐II genes are associated with outcomes of specific immunotherapy for allergic rhinitis
Zhao, Y., Zhao, Y., Zhang, Y., & Zhang, L. (2019) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22384 · Cited by 12
Injection Immunotherapy for Inhalant Allergens
Nelson, H. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-323-08593-9.00088-7 · Cited by 12
Real-world evidence of allergen immunotherapy
Buta, F., Paoletti, G., Bragato, M. C., Giovannini, M., Canonica, G. W., & Heffler, E. M. (2024) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000001026 · Cited by 11
Fan, Y., Ji, P., Leonard-Segal, A., & Sahajwalla, C. G. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23720 · Cited by 11
New modalities of allergen immunotherapy
Ramesh, M., & Karagic, M. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1502126 · Cited by 11
Subcutaneous and sublingual allergen-specific immunotherapy: a tale of two routes
Incorvaia, C., Ciprandi, G., Nizi, M. C., Makri, E., & Ridolo, E. (2020) · European Annals of Allergy and Clinical Immunology · doi:10.23822/eurannaci.1764-1489.150 · Cited by 11
Omalizumab and allergen immunotherapy for respiratory allergies
Filippo, M. D., Votto, M., Caminiti, L., Carella, F., Castro, G. D., Landi, M., Olcese, R., Panasiti, I., Vernich, M., Barberi, S., et al. (2022) · Allergologia et Immunopathologia · doi:10.15586/aei.v50i6.495 · Cited by 11
Anagnostou, K., Islam, S., King, Y., Foley, L., Pasea, L., Palmer, C., Bond, S. J., Ewan, P. W., & Clark, A. T. (2014) · Efficacy and Mechanism Evaluation · doi:10.3310/eme01040 · Cited by 11
Allergic rhinitis in children: from diagnosis to therapy
Asmanov, A. I., Pivneva, N. D., Zlobina, N. V., & Pampura, A. N. (2020) · Russian Bulletin of Otorhinolaryngology · doi:10.17116/otorino20208501174 · Cited by 11
Tradition and innovation: Finding the right balance
Durham, S. R. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.02.034 · Cited by 11
Self-citationImmunological Approaches for Tolerance Induction in Allergy
Conrad, M. L., Renz, H. E., & Blaser, K. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_128 · Cited by 11
Management of comorbidities in difficult and severe asthma
Khan, J., Moran, B., McCarthy, C., Butler, M. W., & Franciosi, A. N. (2023) · Breathe · doi:10.1183/20734735.0133-2023 · Cited by 13
Sublingual immunotherapy in allergic rhinitis: indications, efficacy and safety
Kariyawasam, H. H., Rotiroti, G., & Robinson, D. S. (2013) · Rhinology Journal · doi:10.4193/rhin11.268 · Cited by 10
Guiding principles of subcutaneous immunotherapy for allergic rhinitis in Japan
Okamoto, Y., Ohta, N., Okano, M., Kamijo, A., Gotoh, M., Suzuki, M., Takeno, S., Terada, T., Hanazawa, T., Horiguchi, S., et al. (2013) · Auris Nasus Larynx · doi:10.1016/j.anl.2013.06.003 · Cited by 10
Specific Immunotherapy (hyposensitization) for IgE-mediated allergic diseases*
Kleine‐Tebbe, J., Bufe, A., Ebner, C., Eigenmann, P., Friedrichs, F., Fuchs, T., Huttegger, I., Jung, J. Y., Klimek, L., Kopp, M., et al. (2010) · GRO · Cited by 10
Ridolo, E., Incorvaia, C., Gritti, B. L., & Passalacqua, G. (2016) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000330 · Cited by 10
Wise, S. K., & Schlosser, R. J. (2012) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2012.06.008 · Cited by 10
Review on immunotherapy in airway allergen sensitised patients.
van der Valk, J. P. M., de Jong, N. W., & van Wijk, R. G. (2015) · PubMed · Cited by 10
Systemic reactions to subcutaneous immunotherapy
Mustafa, S. S., Bingemann, T. A., Blue, H., Conn, K. M., Hanley, T., & Ramsey, A. C. (2019) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2019.06.021 · Cited by 10
Roger, A., Malet, A., Moreno, V., Parra, A., Gutiérrez, D., Lleonart, R., Moreno, F., Valero, A., Navarro, B., Hinojosa, B., et al. (2020) · Immunotherapy · doi:10.2217/imt-2019-0205 · Cited by 10
Lavaud, F., Fore, M., Fontaine, J.-F., Perotin, J., & Frederic de, B. L. A. Y. (2013) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2013.08.006 · Cited by 10
Patients on subcutaneous allergen immunotherapy are at risk of intramuscular injections
Kim, L., Nevis, I., Potts, R., Eeuwes, C., Dominic, A., & Kim, H. L. (2014) · Allergy Asthma and Clinical Immunology · doi:10.1186/1710-1492-10-22 · Cited by 10
Treatment trends in allergic rhinitis and asthma: a British ENT survey
Natt, R. S., Karkos, P. D., Natt, D. K., Theochari, E. G., & Karkanevatos, A. (2011) · BMC Ear Nose and Throat Disorders · doi:10.1186/1472-6815-11-3 · Cited by 10
Systemic Therapies in Managing Sinonasal Inflammation
DeMarcantonio, M. A., & Han, J. K. (2010) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2010.02.013 · Cited by 10
Willingness to pay for allergy-vaccination among Danish patients with respiratory allergy
Petersen, K. D., Gyrd‐Hansen, D., Linneberg, A. R., Dahl, R., Larsen, J. N., Løwenstein, H., & Kronborg, C. (2010) · International Journal of Technology Assessment in Health Care · doi:10.1017/s026646230999081x · Cited by 10
Moxham, T., Fox, K. R., Hillsdon, M. M., Green, C., Campbell, J., Foster, C., Mutrie, N., & Searle, J. (2012) · Clinical Governance An International Journal · doi:10.1108/cgij.2012.24817caa.002 · Cited by 10
Mahler, V., Klein, C., Sager, A., & Zimmermann, J. (2017) · Immunity Inflammation and Disease · doi:10.1002/iid3.141 · Cited by 9
Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
Wang, J., Qiu, L., Chen, Y., & Chen, M. (2021) · Open Medicine · doi:10.1515/med-2021-0285 · Cited by 9
Major Allergen Content in Allergen Immunotherapy Products: The Limited Value of Numbers
Becker, S., Fassio, F., Muñoz‐Cano, R., Klimek, L., Vidal, C., Heath, M. D., Kündig, T. M., Vogelberg, C., Toran, C., Jensen‐Jarolim, E., et al. (2022) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0822 · Cited by 9
Injection and Sublingual Immunotherapy in the Management of Allergies Affecting the Unified Airway
Leatherman, B. D. (2008) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2007.11.016 · Cited by 9
Roxbury, C. R., & Lin, S. Y. (2017) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2017.08.011 · Cited by 11
Rajakulasingam, R. K., Farah, N., Huber, P. A. J., Durham, S. R., Clark, A. T., Nasser, S. M., & Krishna, M. T. (2017) · Clinical & Experimental Allergy · doi:10.1111/cea.13052 · Cited by 9
Self-citationSCIT Versus SLIT: Which One Do You Recommend, Doc?
Chaaban, M. R., Mansi, A., Tripple, J. W., & Wise, S. K. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.02.004 · Cited by 9
Bona, D. D., Carlucci, P., Spataro, F., Paoletti, G., Heffler, E. M., Pulkanen, J., Macchia, L., Giacco, S. D., Agache, I. O., Jutel, M., et al. (2023) · Clinical & Experimental Allergy · doi:10.1111/cea.14311 · Cited by 9
Safety of intradermal skin tests for inhalants and foods: a prospective study
Gordon, B. R., Hurst, D. S., Fornadley, J. A., & Hunsaker, D. H. (2012) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21091 · Cited by 9
Updating the role played by immunotherapy for allergic rhinitis: meta‐analysis
Cingi, C., Muluk, N. B., Hancı, D., Ulusoy, S., & Sahin, F. (2014) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21447 · Cited by 9
Fernández, T. D., Alcaide, E. G., Doña, I., Campo, P., Rondón, C., González, M., Gómez, F., Palomares, F., Salas, M. L., Blanca, M., et al. (2015) · Scientific Reports · doi:10.1038/srep14482 · Cited by 9
Mims, J. “. (2011) · Facial Plastic Surgery Clinics of North America · doi:10.1016/j.fsc.2011.10.002 · Cited by 8
Sublingual immunotherapy for children: Are we there yet?
Campbell, D. E. (2009) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2009.02.003 · Cited by 9
Nature of Regulatory T Cells in the Context of Allergic Disease
Özdemir, C., Akdiş, M., & Akdiş, C. A. (2008) · Allergy Asthma and Clinical Immunology · doi:10.1186/1710-1492-4-3-106 · Cited by 9
Aktueller Stellenwert der sublingualen Immuntherapie bei allergischen Krankheiten
Kleine‐Tebbe, J., Bachert, C., Bergmann, K., Bieber, T. R. M., Brehler, R., Friedrichs, F., Fuchs, T., Klimek, L., Kopp, M., Lepp, U. S., et al. (2007) · Allergo Journal · doi:10.1007/bf03361666 · Cited by 9
Paoletti, G., Nappi, E., Bragato, M. C., Valli, P. V., Giovannini, M., Gargano, D., Pecoraro, L., Diso, D., Barbaglia, S., Canonica, G. W., et al. (2024) · World Allergy Organization Journal · doi:10.1016/j.waojou.2024.101015 · Cited by 8
Is Faster Safer? Cluster Versus Short Conventional Subcutaneous Allergen Immunotherapy
Quiralte, J., Justicia, J. L., Cardona, V., Davila, I. J., Moreno, E., Ruiz-León, B., & Garcia, M. (2013) · Immunotherapy · doi:10.2217/imt.13.133 · Cited by 8
Bager, P., Poulsen, G., Wohlfahrt, J., & Melbye, M. (2024) · Allergy · doi:10.1111/all.16026 · Cited by 8
Pham‐Thi, N., Bousiquier, P., & Chartier, A. (2012) · Revue française d'allergologie · doi:10.1016/j.reval.2011.12.002 · Cited by 8
Clinical Immunology Review Series: An approach to the patient with allergy in childhood
Sporik, R. B., Henderson, J., & Hourihane, J. O. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03852.x · Cited by 8
Past, Present and Future Therapeutics of Asthma: A Review
Tanaka, A. (2015) · Journal of General and Family Medicine · doi:10.14442/jgfm.16.3_158 · Cited by 9
Corticosteroids for Allergic Rhinitis
Petersen, T. H., & Agertoft, L. (2016) · Current Treatment Options in Allergy · doi:10.1007/s40521-016-0075-3 · Cited by 8
Allergen immunotherapy for the treatment of respiratory allergies in the elderly
Hur, G. Y., Lee, J.-H., & Park, H. (2017) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000370 · Cited by 8
Alum‐adjuvanted allergoids induce functional IgE‐blocking antibodies
Reithofer, M., Böll, S., Kitzmüller, C., Horak, F., Sotoudeh, M., Bohle, B., & Jahn‐Schmid, B. (2018) · Clinical & Experimental Allergy · doi:10.1111/cea.13120 · Cited by 8
Die spezifische Immuntherapie bei allergischer Rhinitis
Pfaar, O., & Klimek, L. (2008) · HNO · doi:10.1007/s00106-008-1732-z · Cited by 8
Bona, D. D., Paoletti, G., Ordak, M., Dragonieri, S., Cognet-Sicé, J., Scurati, S., & Canonica, G. W. (2024) · World Allergy Organization Journal · doi:10.1016/j.waojou.2024.100985 · Cited by 7
Boursiquot, J.-N., Gagnon, R., Quirt, J., & Ellis, A. K. (2024) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-024-00935-2 · Cited by 7
Gluteal Subcutaneous Atrophy After Depot Steroid Injection for Allergic Rhinitis
Ameratunga, R. (2012) · World Allergy Organization Journal · doi:10.1097/wox.0b013e3182758d80 · Cited by 7
Sánchez, J., Cardona, R., Caraballo, L. R., Serrano, C., Ramírez, R., Díez, S., García, E., Segura, A. M., Cepeda, A. M., & Minotas, M. (2016) · Biomédica · doi:10.7705/biomedica.v36i3.3183 · Cited by 7
Du, W., Fukano, C., Yonemoto, M., Matsuoka, T., Masuyama, K., & Ohashi‐Doi, K. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00710 · Cited by 7
Caimmi, D. P., & Demoly, P. M. (2020) · Revue française d'allergologie · doi:10.1016/j.reval.2020.09.018 · Cited by 7
Kurbacheva, O. M., Pavlova, K. S., & Galitzkaya, M. A. (2017) · Russian Journal of Allergy · doi:10.36691/rja333 · Cited by 7
Cost‐effective Analysis of Subcutaneous vs Sublingual Immunotherapy From the Payor’s Perspective
Hardin, F. M., Eskander, P. N., & Franzese, C. (2021) · OTO Open · doi:10.1177/2473974x211052955 · Cited by 7
Safety of subcutaneous immunotherapy in patients with severe asthma
Chow, T. G., Palka, J. M., Stone, B. D., Trojan, T. D., Epstein, T. G., & Khan, D. A. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.08.014 · Cited by 7
Evolution of Immunotherapy Against Pollen Allergy
Gianni, M. (2023) · Current Protein and Peptide Science · doi:10.2174/1389203724666230303091754 · Cited by 7
Sola, J., Sánchez, V., Landeta, A., Madariaga, B., Martı́nez, A., & Álvarez-Cuesta, E. (2015) · Immunotherapy · doi:10.2217/imt.15.8 · Cited by 7
Malling, H. ‐., Thomsen, A. B., & Andersen, J. S. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01908.x · Cited by 7
Ras, L., de Groot, H., Stengs, C. H. M., & van Weissenbruch, R. (2015) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2015.10.018 · Cited by 7
Utility and Comparative Efficacy of Recombinant Allergens Versus Allergen Extract
Patel, H. D., Chambliss, J., & Gupta, M. R. (2017) · Current Allergy and Asthma Reports · doi:10.1007/s11882-017-0727-9 · Cited by 7
Comparative analysis of sublingual immunotherapy medicines for adherence and clinical outcomes
Kim, J., Lee, Y., Yi, K., Kim, S., Mun, S. J., & Cho, K. (2019) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-019-05656-6 · Cited by 7
Metadata
- Authors
- Calderon, M. A., Alves, B., Jacobson, M., Hurwitz, B., Sheikh, A., & Durham, S.
- Affiliations
- Royal Brompton Hospital; Department of Allergy and Respiratory Medicine; Imperial College School of Medicine at the National Heart and Lung Institute London UK SW3 6LY
- Brighton and Hove City Council (GB)
- Imperial College London (GB)
- King's College London (GB)
- University of Edinburgh (GB)
- Royal Brompton Hospital (GB)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2007-01-24
- Volume
- 2009
- Issue
- 1
- Pages
- CD001936-CD001936
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC7017974
- OpenAlex
- W2153011983
- Cited by
- 678
- References
- 321
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 17 · 2023: 20 · 2022: 31 · 2021: 14 · 2020: 19 · 2019: 24 · 2018: 34 · 2017: 38 · 2016: 41 · 2015: 53 · 2014: 51 · 2013: 50 · 2012: 53
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- allergen immunotherapy, allergic rhinitis, tree pollen, grass pollen, weed pollen, symptom scores, medication use, quality of life, adverse events, placebo comparison, treatment efficacy and safety, treatment duration, allergen sensitivity, allergen avoidance, allergen desensitization, allergen tolerance
- MeSH terms
- Allergens, Desensitization, Immunologic, Rhinitis, Allergic, Seasonal, Humans, Injections, Subcutaneous, Pollen, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
